Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Fetal alcohol syndrome was first described in the literature over 50 years ago and is widely recognized as a devastating public health problem. Prevalence in the U.S. is estimated to be as high as 2.0-7.0 per 1000 individuals in school-age populations. However, prevalence dramatically increases when we consider the full spectrum of prenatal alcohol-associated effects, with estimates of fetal alcohol spectrum disorders (FASD) ranging as high as 2-5% in the U.S. and Western Europe. The diagnosis of FASDs relies upon identifying a range of physical defects and specific neurocognitive and behavioral profiles. FAS is at the most severe end of the spectrum with multiple diagnostic criteria stating reliance on the recognition of at least two of the three cardinal facial features; a smooth philtrum, a thin upper lip vermillion and reduced palpebral fissure length. Alcohol exposed individuals who lack the required criteria for a FAS diagnosis are inherently challenging to identify and subsequently suffer high rates of missed diagnoses and misdiagnosis. In this chapter, we review the 2D and 3D imaging based methods for identifying the range of FASD associated facial dysmorphism across the FASD spectrum, and discuss the identification of and relationships between the face, brain and neurocognitive performance.

Original publication

DOI

10.1007/978-3-031-32483-3_24

Type

Chapter

Book title

Alcohol and Alcohol-related Diseases

Publication Date

24/10/2023

Pages

437 - 453